i10 Productivity
Rankings

Pfizer Inc. ScientistsOthers i10 Productivity Rankings 2024

Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index"Also see: Universities Rankings 2024 (Sort by : Total i10 Index)  and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)

* Total i10 Index Rankings
World Rank
14,224
Country Rank
4,864
Institution Rank : 2
United States
Seng H Cheng
rare disease
gene therapy
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
287
167
0.582
* Total i10 Index Rankings
World Rank
47,168
Country Rank
15,509
Institution Rank : 5
United States
Robert E Chapin
in vitro toxicology
predictive tox
developmental and reproductive toxicology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
164
75
0.457
* Total i10 Index Rankings
World Rank
48,080
Country Rank
15,801
Institution Rank : 6
United States
Amit Kalgutkar
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
162
111
0.685
* Total i10 Index Rankings
World Rank
70,257
Country Rank
22,400
Institution Rank : 9
United States
Bruno Hancock
powder compaction flow segregation computational modeling
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
131
102
0.779
* Total i10 Index Rankings
World Rank
113,435
Country Rank
34,560
Institution Rank : 13
United States
Timothy J Mccarthy
Drug Development
Positron Emission Tomography
Biomarkers
Imaging
Digital Medicine
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
98
52
0.531
* Total i10 Index Rankings
World Rank
124,596
Country Rank
37,738
Institution Rank : 15
United States
Jeffrey Pfefferkorn
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
92
51
0.554
* Total i10 Index Rankings
World Rank
145,042
Country Rank
43,241
Institution Rank : 16
United States
Pratap Singh
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
35
0.422
* Total i10 Index Rankings
World Rank
148,379
Country Rank
44,142
Institution Rank : 17
United States
Luis Jodar
vaccines
infectious diseases
clinical trials
epidemiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
69
0.852
* Total i10 Index Rankings
World Rank
158,089
Country Rank
46,699
Institution Rank : 21
United States
Adriano Arguedas|Adriano Arguedas Mohs, Adriano Gerardo Arguedas Mohs
pneumococcal vaccines
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
78
25
0.321
* Total i10 Index Rankings
World Rank
211,773
Country Rank
60,741
Institution Rank : 34
United States
Boris Gorovits
bioanalysis of biotherapeutics
immunogenicity of biotherapeutics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
62
43
0.694
* Total i10 Index Rankings
World Rank
220,412
Country Rank
62,916
Institution Rank : 36
United States
Tristan Maurer
Drug Discovery
DMPK
Quantitative Systems Pharmacology
PBPK
Data Science
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
60
43
0.717
* Total i10 Index Rankings
World Rank
231,278
Country Rank
65,586
Institution Rank : 39
United States
Richat Abbas (Richat Abbas Borhan)
Drug Research and Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
58
25
0.431
* Total i10 Index Rankings
World Rank
239,661
Country Rank
67,782
Institution Rank : 41
United States
Andy Koenig
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
39
0.696
* Total i10 Index Rankings
World Rank
239,757
Country Rank
67,798
Institution Rank : 42
United States
William Somers
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
56
38
0.679
* Total i10 Index Rankings
World Rank
246,353
Country Rank
69,539
Institution Rank : 46
United States
Kimberly Cameron
drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
55
26
0.473
* Total i10 Index Rankings
World Rank
266,166
Country Rank
74,565
Institution Rank : 47
United States
Xun Lin
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
51
41
0.804
* Total i10 Index Rankings
World Rank
273,195
Country Rank
76,283
Institution Rank : 50
United States
Travis T Wager
Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
50
35
0.700
* Total i10 Index Rankings
World Rank
286,386
Country Rank
79,493
Institution Rank : 51
United States
Rob Webster
Drug Metabolism
Biotherapeutics
Safety
ADME
PKPD
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
48
31
0.646
* Total i10 Index Rankings
World Rank
287,698
Country Rank
79,784
Institution Rank : 52
United States
Kaushik Dutta
Vaccine process development
ADC development
NMR Spectroscopy
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
48
23
0.479
* Total i10 Index Rankings
World Rank
298,065
Country Rank
82,342
Institution Rank : 54
United States
Claire Steppan
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
46
37
0.804
* Total i10 Index Rankings
World Rank
299,732
Country Rank
82,772
Institution Rank : 56
United States
Lindsay E King
Biotherapeutics
Bioanalysis
Antibody Drug Conjugates
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
46
31
0.674
* Total i10 Index Rankings
World Rank
316,101
Country Rank
86,758
Institution Rank : 61
United States
Jeremy D Gale
Clinical trials
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
44
22
0.500
* Total i10 Index Rankings
World Rank
324,176
Country Rank
88,771
Institution Rank : 62
United States
Robert Stanton
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
43
19
0.442
* Total i10 Index Rankings
World Rank
324,867
Country Rank
88,927
Institution Rank : 63
United States
Jim Eyles
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
43
12
0.279
* Total i10 Index Rankings
World Rank
329,311
Country Rank
90,165
Institution Rank : 65
United States
Mark Rozenbaum
cost effectiveness
infectious diseases
oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
42
31
0.738
Total i10 Index AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 i10 Index Metrics
University Rank Country Rank Region Rank World Rank Name Country University / Institution Subject
Research Areas
Total Last 6 Year Last 6 year/total
2 4,864 5,427 14,224 United States United States Pfizer Inc. Pfizer Inc. Others

rare disease | gene therapy |

287 167 0.582
5 15,509 17,510 47,168 United States United States Pfizer Inc. Pfizer Inc. Others

in vitro toxicology | predictive tox | developmental and reproductive toxicology |

164 75 0.457
6 15,801 17,846 48,080 United States United States Pfizer Inc. Pfizer Inc. Others

162 111 0.685
9 22,400 25,437 70,257 United States United States Pfizer Inc. Pfizer Inc. Others

powder compaction flow segregation computational modeling |

131 102 0.779
13 34,560 39,458 113,435 United States United States Pfizer Inc. Pfizer Inc. Others

Drug Development | Positron Emission Tomography | Biomarkers | Imaging | Digital Medicine |

98 52 0.531
15 37,738 43,050 124,596 United States United States Pfizer Inc. Pfizer Inc. Others

92 51 0.554
16 43,241 49,362 145,042 United States United States Pfizer Inc. Pfizer Inc. Others

83 35 0.422
17 44,142 50,377 148,379 United States United States Pfizer Inc. Pfizer Inc. Others

vaccines | infectious diseases | clinical trials | epidemiology |

81 69 0.852
21 46,699 53,336 158,089 United States United States Pfizer Inc. Pfizer Inc. Others

pneumococcal vaccines |

78 25 0.321
34 60,741 69,308 211,773 United States United States Pfizer Inc. Pfizer Inc. Others

bioanalysis of biotherapeutics | immunogenicity of biotherapeutics |

62 43 0.694
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Adscientificindex
36 62,916 71,774 220,412 United States United States Pfizer Inc. Pfizer Inc. Others

Drug Discovery | DMPK | Quantitative Systems Pharmacology | PBPK | Data Science |

60 43 0.717
39 65,586 74,805 231,278 United States United States Pfizer Inc. Pfizer Inc. Others

Drug Research and Development |

58 25 0.431
41 67,782 77,285 239,661 United States United States Pfizer Inc. Pfizer Inc. Others

56 39 0.696
42 67,798 77,303 239,757 United States United States Pfizer Inc. Pfizer Inc. Others

56 38 0.679
46 69,539 79,260 246,353 United States United States Pfizer Inc. Pfizer Inc. Others

drug discovery |

55 26 0.473
47 74,565 84,990 266,166 United States United States Pfizer Inc. Pfizer Inc. Others

51 41 0.804
50 76,283 86,935 273,195 United States United States Pfizer Inc. Pfizer Inc. Others

Drug Discovery |

50 35 0.700
51 79,493 90,561 286,386 United States United States Pfizer Inc. Pfizer Inc. Others

Drug Metabolism | Biotherapeutics | Safety | ADME | PKPD |

48 31 0.646
52 79,784 90,890 287,698 United States United States Pfizer Inc. Pfizer Inc. Others

Vaccine process development | ADC development | NMR Spectroscopy |

48 23 0.479
54 82,342 93,811 298,065 United States United States Pfizer Inc. Pfizer Inc. Others

46 37 0.804
56 82,772 94,287 299,732 United States United States Pfizer Inc. Pfizer Inc. Others

Biotherapeutics | Bioanalysis | Antibody Drug Conjugates |

46 31 0.674
61 86,758 98,789 316,101 United States United States Pfizer Inc. Pfizer Inc. Others

Clinical trials |

44 22 0.500
62 88,771 101,072 324,176 United States United States Pfizer Inc. Pfizer Inc. Others

43 19 0.442
63 88,927 101,245 324,867 United States United States Pfizer Inc. Pfizer Inc. Others

43 12 0.279
65 90,165 102,627 329,311 United States United States Pfizer Inc. Pfizer Inc. Others

cost effectiveness | infectious diseases | oncology |

42 31 0.738